```html

Bamboo Spine (Ankylosing Spondylitis)

What is Bamboo Spine (Ankylosing Spondylitis)?

Ankylosing spondylitis (AS) is a chronic, inflammatory arthritis that primarily affects the spine and sacroiliac joints. Over time, the inflammation can cause the vertebrae to fuse together, giving the spine a rigid, “bamboo‑like” appearance on radiographs – a finding known as a bamboo spine. AS belongs to a broader group of diseases called spondyloarthropathies, which share common genetic and clinical features.<sup>1</sup>

The disease usually begins in early adulthood (late teens to early 30s) and is more common in men than women (about 2–3 : 1). While back pain is the hallmark symptom, the condition can also involve peripheral joints, eyes, heart, and lungs.<sup>2</sup>

Common Causes

AS is not caused by a single factor; it results from a mix of genetic susceptibility, immune system dysfunction, and environmental triggers. The most important known contributors are:

• HLA‑B27 gene – present in 90% of patients with AS; it predisposes the immune system to attack spinal tissues.
• Other genetic markers – ERAP1, IL23R, and CTLA4 variants add modest risk.
• Immune dysregulation – abnormal activation of Th17 cells leads to excess production of inflammatory cytokines (IL‑17, IL‑23, TNF‑α).
• Gut microbiome alterations – studies suggest that changes in intestinal bacteria may trigger immune responses that cross‑react with joint tissue.<sup>3</sup>
• Mechanical stress – repetitive micro‑trauma to the sacroiliac joints may initiate inflammation in genetically predisposed individuals.
• Infection – certain bacterial infections (e.g., Chlamydia trachomatis) have been linked to reactive arthritis, which can evolve into spondyloarthritis.
• Smoking – increases disease severity and accelerates radiographic progression.
• Obesity – excess weight adds mechanical load to the spine and may worsen inflammation.
• Vitamin D deficiency – low levels are associated with higher disease activity, though causality is not fully proven.
• Trauma or surgery – rare cases report disease onset after spinal injury or major orthopedic procedures.

Associated Symptoms

Because AS is a systemic disease, patients often experience a cluster of symptoms beyond back pain:

• Inflammatory low‑back pain – worse at night, improves with activity.
• Morning stiffness lasting >30 minutes.
• Neck pain and limited cervical rotation.
• Peripheral arthritis – typically affecting hips, shoulders, knees, or ankles.
• Enthesitis – inflammation at tendon/ligament insertions (e.g., heel → Achilles tendinitis).
• Uveitis – painful, red eye that can threaten vision if untreated.
• Cardiovascular involvement – aortitis, heart‑block, or valve disease in advanced disease.
• Respiratory limitation – reduced chest expansion leading to shortness of breath.
• Fatigue and occasional low‑grade fever.
• Gut symptoms – inflammatory bowel disease (IBD) co‑occurs in ~5–10% of patients.

When to See a Doctor

Early medical evaluation can prevent irreversible spinal fusion and organ complications. Seek care if you notice:

• Persistent low‑back or buttock pain that is worse at rest and improves with movement.
• Morning stiffness lasting >30 minutes for more than three weeks.
• New eye redness, pain, or blurry vision (possible uveitis).
• Unexplained swelling or pain in the heels, knees, or hips.
• Decreased chest expansion or shortness of breath on exertion.
• Family history of ankylosing spondylitis or other spondyloarthropathies.

Diagnosis

Diagnosing AS requires a combination of clinical assessment, imaging, and laboratory studies.

Clinical evaluation

• Detailed history focusing on pain pattern, stiffness, extra‑articular features (eye, skin, gut).
• Physical exam checking spinal mobility (Schober test, chest expansion), sacroiliac tenderness, and peripheral joint involvement.

Imaging studies

• X‑ray – classic “bamboo spine” appearance from fusion of the lumbar vertebrae; sacroiliitis is the earliest radiographic sign.
• MRI – detects active inflammation (bone marrow edema) before X‑ray changes, useful for early diagnosis.
• CT scan – provides detailed view of bone ankylosis when X‑ray is equivocal.

Laboratory tests

• HLA‑B27 typing – positive in ~90% of patients, but a negative result does not exclude disease.
• Inflammatory markers – ESR and CRP are often elevated, reflecting disease activity.
• Rheumatoid factor (RF) and anti‑CCP – usually negative, helping differentiate from rheumatoid arthritis.

Classification criteria

The 2016 Assessment of SpondyloArthritis international Society (ASAS) criteria are widely used. They require either:

1. Imaging‑plus‑clinical features (sacroiliitis on MRI/CT plus ≥1 SpA feature), or
2. HLA‑B27 plus ≥2 SpA features.

These criteria improve early detection before extensive fusion occurs.<sup>4</sup>

Treatment Options

There is no cure for AS, but modern therapy can control inflammation, preserve mobility, and reduce complications.

Medication

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – first‑line for pain and stiffness (e.g., naproxen, ibuprofen). Continuous NSAID use may slow radiographic progression in some patients.<sup>5</sup>
• Biologic disease‑modifying anti‑rheumatic drugs (bDMARDs) – TNF inhibitors (adalimumab, etanercept, infliximab, golimumab, certolizumab) are highly effective for refractory disease.
• IL‑17 inhibitors – secukinumab and ixekizumab target the IL‑17 pathway, useful when TNF blockers fail or are contraindicated.
• JAK inhibitors – upadacitinib and tofacitinib have shown benefit in AS patients with inadequate response to biologics.
• Corticosteroids – short courses may relieve acute flares but are not recommended for long‑term use due to side effects.
• Analgesics – acetaminophen or tramadol for breakthrough pain when NSAIDs are insufficient.

Physical therapy & rehabilitative measures

• Daily stretching – focus on spine extension, chest expansion, and hip flexors.
• Strength training – core and postural muscles to support the vertebral column.
• Hydrotherapy – warm water reduces load on joints while allowing full range of motion.
• Postural education – ergonomic adjustments for sitting, sleeping, and lifting.

Surgical options

• Spinal osteotomy – corrective surgery for severe kyphosis when quality of life is markedly impaired.
• Joint replacement – total hip arthroplasty for end‑stage hip arthritis.

Lifestyle & home care

• Quit smoking – improves response to biologics and slows progression.
• Maintain a healthy weight – reduces mechanical stress on the spine.
• Regular aerobic activity (e.g., walking, swimming) – promotes cardiovascular health and chest expansion.
• Apply heat or cold packs to painful areas as needed.
• Adopt a balanced diet rich in omega‑3 fatty acids, calcium, and vitamin D.

Prevention Tips

While you cannot prevent a genetic predisposition, you can lower the risk of severe disease and complications by:

• Early screening if you have a family history of AS or are HLA‑B27 positive.
• Staying physically active from adolescence onward.
• Avoiding tobacco and limiting alcohol consumption.
• Managing comorbid conditions such as IBD, psoriasis, or metabolic syndrome promptly.
• Regular eye examinations if you have had prior uveitis.
• Vaccinations (influenza, pneumococcal) – especially important for patients on immunosuppressive therapy.

Emergency Warning Signs

References

1. Mayo Clinic. Ankylosing spondylitis. https://www.mayoclinic.org. Accessed April 2026.
2. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Ankylosing Spondylitis. https://www.niams.nih.gov. Accessed April 2026.
3. Rudwaleit M, et al. The role of the gut microbiome in spondyloarthritis. *Nat Rev Rheumatol*. 2022;18(6):321‑334.
4. ASAS‑EULAR Management Recommendations for Ankylosing Spondylitis. *Ann Rheum Dis*. 2016;75(6):958‑969.
5. Wang R, et al. NSAID use and radiographic progression in ankylosing spondylitis: a systematic review. *Arthritis Care Res*. 2021;73(5):789‑797.
6. Ward MM, et al. Biologic therapy for ankylosing spondylitis. *Lancet*. 2020;395(10224):215‑226.

```